Evidence map›Paper›PMID 41484149›Full record

ArticleNature communications2026

CUL4A-DDB1-DCAF10 is an N-recognin for N-terminally acetylated Src kinases.

Nora Kremer, Franziska Mueller, Hang Nguyen, Louisa Schulz, Tanja Popp, Elena Artes, Julian Wolters, Michael Renner, Ingrid Vetter, Stefano Maffini and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nora Kremer *Department of Medicine II, LMU University Hospital, Munich, Germany.ORCID http://orcid.org/0009-0002-5532-3088
Franziska Mueller *Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany.ORCID http://orcid.org/0000-0002-4880-9269
Hang NguyenDepartment of Medicine II, LMU University Hospital, Munich, Germany.ORCID http://orcid.org/0009-0008-9305-5559
Louisa SchulzDepartment of Medicine II, LMU University Hospital, Munich, Germany.ORCID http://orcid.org/0009-0003-2235-0191
Tanja PoppDepartment of Medicine II, LMU University Hospital, Munich, Germany.
Elena ArtesDepartment of Medicine II, LMU University Hospital, Munich, Germany.
Julian WoltersDepartment of Medicine II, LMU University Hospital, Munich, Germany.ORCID http://orcid.org/0009-0009-4962-1039
Michael RennerDepartment of Medicine II, LMU University Hospital, Munich, Germany.ORCID http://orcid.org/0009-0009-8169-9442
Ingrid VetterDepartment of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany.
Stefano MaffiniDepartment of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany.
Maria S RoblesFaculty of Medicine, Institute of Medical Psychology and Biomedical Center (BMC), LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0001-9149-8761
Andrea MusacchioDepartment of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany.ORCID http://orcid.org/0000-0003-2362-8784
Tanja BangeDepartment of Medicine II, LMU University Hospital, Munich, Germany. tanja.bange@med.uni-muenchen.de.ORCID http://orcid.org/0000-0002-9680-8586

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 5041 140321
6 · The paper itself

Abstract

Co-translational N-terminal modifications such as methionine excision, acetylation, and myristoylation govern protein stability, localization, and folding. Disruption can expose N-terminal degrons that trigger ubiquitin-mediated degradation, safeguarding the proteome. N-terminal acetylation usually protects proteins from degradation, but can also promote it through the Ac/N-degron pathway. Src-family kinases (SFKs), signaling enzymes implicated in tumorigenesis, require N-terminal myristoylation for function. Using peptide pull-downs, mass spectrometry, and AlphaFold 3 predictions, we identify DCAF10 as the E3 ligase substrate receptor for alternatively N-terminally acetylated SFKs. Combining siRNA-mediated knockdown and CRISPR/Cas9-mediated knockout of endogenous Lyn with inducible Lyn-GFP variants confirms that DCAF10 regulates SFK levels by recognizing an N-terminal acetylated glycine residue. In vitro, a CUL4A-DDB1-DCAF10 complex ubiquitinates N-terminally acetylated SFKs. Thus, we define a novel N-degron pathway that monitors replacement of myristoylation by acetylation and activates degradation of SFKs upon acetylation. This mechanism may extend to other N-terminally myristoylated proteins beyond SFKs.

Indexed as

Cullin ProteinsDNA-Binding Proteinssrc-Family KinasesAcetylationCRISPR-Cas SystemsHEK293 CellsHumansProtein Processing, Post-TranslationalProteolysisUbiquitinationUbiquitin-Protein LigasesCUL4A protein, humanCullin ProteinsDDB1 protein, humanDNA-Binding Proteinslyn protein-tyrosine kinasesrc-Family KinasesUbiquitin-Protein Ligases

Identifiers

PMID41484149
PMCPMC12775124

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.